We are live on
!
Find out more
AACP
Advantage Alpha Capital Partners Portfolio holdings
AUM
$332M
1-Year Est. Return
12.78%
This Fund
S&P 500
This Quarter
Est. Return
+8.8%
1 Year Est. Return
+12.78%
3 Year Est. Return
+79.23%
5 Year Est. Return
+110.24%
10 Year Est. Return
–
AUM
$332M
AUM Growth
-$39.1M
(-11%)
Cap. Flow
-$62.1M
Cap. Flow
% of AUM
-18.72%
Top 10 Holdings %
Top 10 Hldgs %
18.07%
Holding
140
New
21
Increased
26
Reduced
83
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Harrow
HROW
|
+$4.2M |
| 2 |
Transcat
TRNS
|
+$3.76M |
| 3 |
Ryman Hospitality Properties
RHP
|
+$3.16M |
| 4 |
Universal Technical Institute
UTI
|
+$3M |
| 5 |
WAY
Waystar Holding Corp
WAY
|
+$2.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ceco Environmental
CECO
|
+$6.18M |
| 2 |
SharkNinja
SN
|
+$4.32M |
| 3 |
Workiva
WK
|
+$4.31M |
| 4 |
Magnite
MGNI
|
+$4.3M |
| 5 |
FTAI Aviation
FTAI
|
+$4.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 35.84% |
| 2 | Technology | 18.8% |
| 3 | Healthcare | 15.52% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Financials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
PTC Therapeutics
PTCT
$5.82B
| $221K | 0.07% |
3,595
-579
| -14% | -$30.2K |
|
127
UMB Financial
UMBF
$11B
| $220K | 0.07% |
+1,859
| New | +$214K |
|
128
Texas Capital Bancshares
TCBI
$4.28B
| $210K | 0.06% |
+2,490
| New | +$213K |
|
129
BancFirst
BANF
$3.71B
| $208K | 0.06% |
+1,648
| New | +$213K |
|
130
Axos Financial
AX
$5.55B
| $202K | 0.06% |
+2,388
| New | +$208K |
|
131
Agilysys
AGYS
$3.37B
| – | – |
-23,728
| Closed | -$2.72M |
|
132
Boot Barn
BOOT
$4.72B
| – | – |
-23,136
| Closed | -$3.52M |
|
133
Collegium Pharmaceutical
COLL
$788M
| – | – |
-15,531
| Closed | -$459K |
|
134
Castle Biosciences
CSTL
$1.02B
| – | – |
-16,021
| Closed | -$327K |
|
|
FOLD
135
DELISTED
Amicus Therapeutics
FOLD
| – | – |
-35,082
| Closed | -$201K |
|
136
Federal Signal
FSS
$7.21B
| – | – |
-32,819
| Closed | -$3.49M |
|
137
Kiniksa Pharmaceuticals
KNSA
$6.1B
| – | – |
-11,020
| Closed | -$305K |
|
138
Ligand Pharmaceuticals
LGND
$5.57B
| – | – |
-1,823
| Closed | -$207K |
|
139
Paymentus
PAY
$4.55B
| – | – |
-77,944
| Closed | -$2.55M |
|
140
Zurn Elkay Water Solutions
ZWS
$7.98B
| – | – |
-62,955
| Closed | -$2.3M |
|
Similar funds
CPA
PAWA
EE
GB
SC
SFG
PA
BCCM
Advantage Alpha Capital Partners's Q3 2025 Portfolio in Review
As of Q3 2025, Advantage Alpha Capital Partners held 140 positions worth $332M, down 11% from $371M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Advantage Alpha Capital Partners withdrew a net $62.1M in Q3 2025, closing 10 positions and reducing 83 holdings. Its most notable exit was Boot Barn, an estimated $3.52M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 36% of assets, down from 36% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Advantage Alpha Capital Partners opened a new position in Harrow worth $5.37M.
- Advantage Alpha Capital Partners's largest Q3 2025 buy was Harrow: 111,553 shares worth $5.37M.
- Advantage Alpha Capital Partners added most to Casella Waste Systems in Q3 2025, an estimated $1.96M increase.
- Advantage Alpha Capital Partners's biggest Q3 2025 reduction was Ceco Environmental, cutting an estimated $6.18M.
- Advantage Alpha Capital Partners fully exited Boot Barn in Q3 2025, selling an estimated $3.52M.
- Advantage Alpha Capital Partners's ten largest holdings make up 18% of its $332M portfolio in Q3 2025.
- Advantage Alpha Capital Partners opened 21 new positions and closed 10 in Q3 2025.
- Advantage Alpha Capital Partners's portfolio value fell 11% quarter-over-quarter to $332M.
Based on Advantage Alpha Capital Partners's 13F filing for Q3 2025, filed 12 Nov 2025.